Drug:
Reaction: DRUG INEFFECTIVE
20250101 - 20251231
No. 801 - 900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 801 | 25129487 |
US |
70 | |
Drug ineffective, Off label use, |
||||
CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE, |
||||
| 802 | 25129499 |
US |
32 | 1 |
Drug ineffective, |
||||
TOFACITINIB, |
||||
| 803 | 25129502 |
US |
24 | 1 |
Drug ineffective, |
||||
TOFACITINIB, |
||||
| 804 | 25129509 |
US |
7 | 2 |
Loss of bladder sensation, Polyuria, Drug ineffective, |
||||
LACOSAMIDE, |
||||
| 805 | 25129616 |
CA |
2 | |
Pericardial effusion, Diarrhoea, Patent ductus arteriosus, Pulmonary hypertension, Drug ineffective, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE, OCTREOTIDE ACETATE, OCTREOTIDE, OCTREOTIDE ACETATE, OCTREOTIDE, DEXTROSE MONOHYDRATE, DEXTROSE, DIAZOXIDE, DIAZOXIDE, HYDROCHLOROTHIAZIDE, |
||||
| 806 | 25129629 |
US |
||
Drug ineffective, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISONE, KENALOG, NIVOLUMAB, |
||||
| 807 | 25129637 |
US |
78 | 1 |
Drug ineffective, |
||||
LINEZOLID, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 808 | 25129668 |
ES |
14 | 2 |
Seizure, Generalised tonic-clonic seizure, Tonic convulsion, Vagal nerve stimulator implantation, Selective mutism, Cognitive disorder, Behaviour disorder, Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, VALPROIC ACID, RUFINAMIDE, LACOSAMIDE, PHENOBARBITAL, CLOBAZAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PERAMPANEL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), LORAZEPAM, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 809 | 25129832 |
US |
||
Drug ineffective, Drug ineffective for unapproved indication, Off label use, |
||||
| 810 | 25129860 |
US |
38 | 2 |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 811 | 25129867 |
CA |
71 | 2 |
Asthma, Dyspnoea, Impaired quality of life, Loss of personal independence in daily activities, Sleep disorder due to a general medical condition, Wheezing, Drug ineffective, |
||||
CICLESONIDE, MEPOLIZUMAB, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
| 812 | 25129878 |
US |
2 | |
Drug ineffective, No adverse event, |
||||
| 813 | 25129885 |
US |
22 | 2 |
Psoriasis, Haemorrhage, Drug ineffective, |
||||
INFLIXIMAB, |
||||
| 814 | 25129922 |
US |
1 | |
Drug ineffective, Product tampering, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 815 | 25129964 |
US |
2 | |
Adenoidectomy, Seizure, Drug ineffective, |
||||
VIGABATRIN, VIGABATRIN, VIGABATRIN, VIGABATRIN, FENFLURAMINE, CLOBAZAM, CLOBAZAM, CLOBAZAM, CLOBAZAM, ERGOCALCIFEROL, MELATONIN, |
||||
| 816 | 25129997 |
IT |
2 | |
Bronchiolitis, Drug ineffective, |
||||
NIRSEVIMAB, |
||||
| 817 | 25130019 |
US |
62 | 1 |
Drug ineffective, Product use in unapproved indication, |
||||
DOFETILIDE, METOPROLOL TARTRATE, METOPROLOL, SOTALOL HYDROCHLORIDE, |
||||
| 818 | 25130054 |
US |
||
Drug ineffective, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, FLUOXETINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ARIPIPRAZOLE, DANAZOL, PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ALPRAZOLAM, |
||||
| 819 | 25130065 |
US |
1 | |
Ankylosing spondylitis, Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 820 | 25130106 |
ES |
52 | 1 |
Intestinal perforation, Epstein-Barr virus infection, Colitis, Drug ineffective, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, CEFTRIAXONE, CEFTRIAXONE SODIUM, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
| 821 | 25130117 |
US |
69 | 2 |
Neoplasm malignant, Drug ineffective, Musculoskeletal stiffness, Fatigue, |
||||
TOFACITINIB, |
||||
| 822 | 25130140 |
US |
5 | |
Drug ineffective, |
||||
MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, DEXTROSE MONOHYDRATE, DEXTROSE, CALCIUM, DIGOXIN, |
||||
| 823 | 25130178 |
JP |
1 | |
Death, Transplant failure, Drug ineffective, |
||||
RITUXIMAB, |
||||
| 824 | 25130185 |
US |
||
Drug ineffective, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 825 | 25130320 |
US |
||
Drug ineffective, |
||||
BEMPEDOIC ACID AND EZETIMIBE, |
||||
| 826 | 25130467 |
US |
56 | 2 |
Drug ineffective, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 827 | 25130511 |
US |
42 | 2 |
Dry eye, Renal disorder, Visual impairment, Headache, Rash, Halo vision, Nasal dryness, Back pain, Drug ineffective, |
||||
ISOTRETINOIN, CELECOXIB, PREGABALIN, |
||||
| 828 | 25130512 |
BR |
68 | 2 |
Blood pressure increased, Blood pressure increased, Pain in extremity, Discomfort, Cardiovascular disorder, Pain, Anxiety, Fatigue, Malaise, Weight decreased, Paraesthesia, Hypoaesthesia, Drug ineffective, Therapeutic product effect incomplete, Wrong technique in product usage process, Inappropriate schedule of product administration, Product packaging quantity issue, Product packaging issue, |
||||
AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE, LOSARTAN, |
||||
| 829 | 25130516 |
US |
70 | 1 |
Metastases to bone, Metastases to pelvis, Metastases to spine, Metastases to liver, Drug intolerance, Drug ineffective, |
||||
CABAZITAXEL, DOCETAXEL, DOCETAXEL ANHYDROUS, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 830 | 25130520 |
US |
||
Seizure, Drug ineffective, |
||||
GANAXOLONE, |
||||
| 831 | 25130522 |
CN |
2 | |
Thyroid mass, Parathyroid disorder, Pain, Drug ineffective, |
||||
ZOLEDRONIC ACID, ZOLEDRONIC ACID, ZOLEDRONIC ACID, |
||||
| 832 | 25130532 |
CA |
30 | 1 |
Inspiratory capacity decreased, Off label use, Drug ineffective for unapproved indication, Drug ineffective, |
||||
DICLOFENAC SODIUM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, NABILONE, NABILONE, NABILONE, NABILONE, NABILONE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, PHENYTOIN, PHENYTOIN, PHENYTOIN, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HUMAN IMMUNOGLOBULIN G, FENTANYL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 833 | 25130547 |
CO |
82 | 1 |
Drug ineffective, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 834 | 25130590 |
US |
||
Drug ineffective, Intentional product use issue, |
||||
VALSARTAN, |
||||
| 835 | 25130711 |
US |
2 | |
Dehydration, Diarrhoea, Drug ineffective, |
||||
LINACLOTIDE, LINACLOTIDE, |
||||
| 836 | 25130724 |
FR |
53 | 2 |
Feeling abnormal, Retinal vein occlusion, Anaemia, Road traffic accident, Fall, Craniocerebral injury, Vertigo, Cervical vertebral fracture, Back disorder, Hand dermatitis, Deafness, Dyspnoea, Fatigue, Dizziness, Chest pain, Influenza, Fear of falling, Tachycardia, Pain in extremity, Fear, Polyuria, Mouth ulceration, Dry mouth, Lip injury, Serum ferritin decreased, Eczema, Drug ineffective, Drug intolerance, Inappropriate schedule of product administration, |
||||
SPIRONOLACTONE, |
||||
| 837 | 25130793 |
IT |
58 | 1 |
Drug ineffective, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, RITUXIMAB, ENTECAVIR, |
||||
| 838 | 25130876 |
CA |
65 | 2 |
Suicidal ideation, Suicide attempt, Adverse drug reaction, Condition aggravated, Drug ineffective, |
||||
APIXABAN, BREXPIPRAZOLE, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), LEMBOREXANT, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, GABAPENTIN, LORAZEPAM, LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEMBOREXANT, MIRTAZAPINE, OLANZAPINE, PANTOPRAZOLE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PRAMIPEXOLE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RISPERIDONE, BREXPIPRAZOLE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VORTIOXETINE, VORTIOXETINE, ZOLPIDEM TARTRATE, |
||||
| 839 | 25130887 |
FR |
71 | 2 |
Immune effector cell-associated haematotoxicity, Cytokine release syndrome, Drug ineffective, |
||||
FLUDARABINE PHOSPHATE, CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, AXICABTAGENE CILOLEUCEL, RITUXIMAB, CARBOPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 840 | 25130889 |
CL |
2 | |
Colitis ulcerative, Clostridium difficile infection, Cytomegalovirus infection, Drug ineffective, |
||||
INFLIXIMAB, |
||||
| 841 | 25130910 |
|||
Drug ineffective, |
||||
LANSOPRAZOLE, |
||||
| 842 | 25130961 |
BR |
4 | 1 |
Drug ineffective, Anti factor VIII antibody increased, Drug intolerance, |
||||
| 843 | 25130980 |
NL |
2 | |
Respiratory tract infection, Drug ineffective, Eczema, Drug hypersensitivity, Asthma, Nausea, Erythema, Stridor, Dyspnoea, Tachypnoea, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 844 | 25131037 |
CA |
33 | 2 |
Abdominal pain, Alopecia, Anorectal disorder, Anxiety, Arthralgia, Attention deficit hyperactivity disorder, Brain fog, Breast pain, Burning sensation, Chills, Cognitive disorder, Drug ineffective, Drug interaction, Dyspepsia, Dysphagia, Dyspnoea, Gastrointestinal pain, Haemorrhage, Headache, Hepatic pain, Hyperhidrosis, Joint swelling, Pain, Paraesthesia, Peripheral swelling, Photosensitivity reaction, Product availability issue, Product formulation issue, Product physical issue, Product shape issue, Product size issue, Product substitution issue, Suspected product tampering, Product taste abnormal, Rash, Rash erythematous, Swelling, Temperature regulation disorder, Therapy interrupted, Tremor, Urinary tract pain, Vaginal disorder, Withdrawal syndrome, |
||||
NIRMATRELVIR AND RITONAVIR, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, AMITRIPTYLINE HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, |
||||
| 845 | 25131066 |
CA |
41 | 2 |
Pneumothorax, Pneumonia, Influenza, Off label use, Drug ineffective, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, RABEPRAZOLE, CELECOXIB, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, |
||||
| 846 | 25131089 |
US |
||
Drug ineffective, |
||||
DOCOSANOL, |
||||
| 847 | 25131090 |
US |
||
Drug ineffective, |
||||
ROCURONIUM BROMIDE, |
||||
| 848 | 25131100 |
US |
||
Drug ineffective, |
||||
DOCOSANOL, |
||||
| 849 | 25131101 |
US |
||
Drug ineffective, |
||||
ROCURONIUM BROMIDE, |
||||
| 850 | 25131106 |
AU |
66 | 2 |
Drug ineffective, |
||||
EPINEPHRINE, ADRENALINUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PROMETHAZINE, |
||||
| 851 | 25131107 |
JP |
27 | 2 |
Drug ineffective, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, MIRTAZAPINE, |
||||
| 852 | 25131115 |
US |
||
Drug ineffective, |
||||
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 853 | 25131123 |
US |
||
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 854 | 25131127 |
US |
||
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 855 | 25131132 |
US |
71 | 1 |
Drug ineffective, Incorrect dose administered, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 856 | 25131137 |
US |
2 | |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 857 | 25131144 |
US |
2 | |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 858 | 25131150 |
US |
1 | |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 859 | 25131162 |
US |
73 | 1 |
Drug ineffective, |
||||
EPINEPHRINE, ADRENALINUM, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, DOBUTAMINE, |
||||
| 860 | 25131165 |
US |
2 | |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 861 | 25131167 |
US |
1 | |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 862 | 25131168 |
US |
1 | |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 863 | 25131170 |
US |
2 | |
Drug ineffective, Incorrect product administration duration, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 864 | 25131171 |
US |
71 | 2 |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 865 | 25131173 |
US |
2 | |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 866 | 25131175 |
US |
2 | |
Palpitations, Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 867 | 25131191 |
US |
2 | |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 868 | 25131192 |
US |
63 | 1 |
Diabetes mellitus inadequate control, Pruritus, Diarrhoea, Toothache, Bipolar disorder, Nasal discomfort, Weight decreased, Somnolence, Arthritis, Lacrimation increased, Dry mouth, Intentional product use issue, Product dose omission issue, Rhinorrhoea, Influenza, Blood glucose decreased, Wrong technique in product usage process, Drug ineffective, Inability to afford medication, |
||||
DEUTETRABENAZINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, MAGNESIUM, MELATONIN, |
||||
| 869 | 25131199 |
US |
2 | |
Drug ineffective, Incorrect dose administered, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 870 | 25131205 |
US |
||
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 871 | 25131207 |
US |
65 | 2 |
Paranasal sinus hyposecretion, Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 872 | 25131208 |
US |
78 | 2 |
Drug ineffective, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 873 | 25131211 |
US |
41 | 2 |
Drug ineffective, Product use in unapproved indication, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 874 | 25131222 |
US |
2 | |
Application site rash, Drug ineffective, |
||||
CLONIDINE TRANSDERMAL SYSTEM, CLONIDINE, CLONIDINE TRANSDERMAL SYSTEM, CLONIDINE, CLONIDINE TRANSDERMAL SYSTEM, CLONIDINE, CLONIDINE TRANSDERMAL SYSTEM, CLONIDINE, |
||||
| 875 | 25131232 |
PL |
29 | 1 |
Drug ineffective, |
||||
ALBUMIN HUMAN, |
||||
| 876 | 25131244 |
US |
43 | 2 |
Drug ineffective, |
||||
CRISABOROLE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, TRETINOIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, FAMOTIDINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, OMALIZUMAB, |
||||
| 877 | 25131301 |
US |
67 | 2 |
Drug ineffective, Skin cancer, |
||||
| 878 | 25131303 |
|||
Drug ineffective, |
||||
DICLOFENAC POTASSIUM, |
||||
| 879 | 25131317 |
RU |
52 | 1 |
Facet joint syndrome, Drug ineffective, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 880 | 25131327 |
US |
69 | 1 |
Drug ineffective, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 881 | 25131333 |
AT |
40 | 2 |
Malignant neoplasm progression, Breast cancer metastatic, Drug ineffective, Fatigue, Weight decreased, |
||||
FULVESTRANT, LETROZOLE, LETROZOLE TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, CAPECITABINE, RIBOCICLIB, PALBOCICLIB, EXEMESTANE, TRASTUZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 882 | 25131348 |
65 | 1 | |
Arthralgia, Myalgia, Fatigue, Headache, Restlessness, Somnolence, Injection site pain, Injection site bruising, Drug ineffective, |
||||
INSULIN LISPRO, ENALAPRIL, ROSUVASTATIN, |
||||
| 883 | 25131390 |
AU |
68 | 2 |
Perineal rash, COVID-19, Limb discomfort, Arthropathy, Lumbosacral plexopathy, Mass, Muscular weakness, Neurogenic bladder, Incorrect route of product administration, Rheumatoid arthritis, Prescribed overdose, Drug ineffective, Herpes zoster, |
||||
BARICITINIB, TOCILIZUMAB, UPADACITINIB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ABATACEPT, RITUXIMAB, |
||||
| 884 | 25131408 |
US |
36 | 2 |
Drug ineffective, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, ATOMOXETINE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PROPOFOL, PROPOFOL, PROPOFOL, LORAZEPAM, GABAPENTIN, GABAPENTIN, SUCCINYLCHOLINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LACOSAMIDE, LITHIUM, LITHIUM BROMATUM, |
||||
| 885 | 25131500 |
ES |
54 | |
Pulmonary mucormycosis, Drug ineffective, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, BASILIXIMAB, |
||||
| 886 | 25131507 |
US |
2 | |
Maternal exposure during pregnancy, Drug ineffective, Pregnancy on contraceptive, |
||||
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE, |
||||
| 887 | 25131511 |
ES |
1 | |
Drug-induced liver injury, Myelosuppression, Drug interaction, Drug ineffective, |
||||
PEMETREXED, PEMETREXED DISODIUM, PACLITAXEL, VINORELBINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MIRTAZAPINE, APIXABAN, CEFTRIAXONE, CEFTRIAXONE SODIUM, TRIMETHOPRIM, ALPRAZOLAM, PEMBROLIZUMAB, AMIKACIN, CARBOPLATIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, LINEZOLID, LINEZOLID, LINEZOLID, LINEZOLID, |
||||
| 888 | 25131538 |
ES |
63 | 1 |
Cutaneous mucormycosis, Pulmonary mucormycosis, Drug ineffective, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, BASILIXIMAB, |
||||
| 889 | 25131715 |
US |
1 | |
Drug ineffective, |
||||
DEUTETRABENAZINE, |
||||
| 890 | 25131886 |
US |
36 | 1 |
Testis cancer recurrent, Eye inflammation, Drug ineffective, Drug ineffective, |
||||
ADALIMUMAB, ADALIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, VEDOLIZUMAB, |
||||
| 891 | 25131888 |
AU |
68 | 1 |
Drug ineffective, |
||||
ROSUVASTATIN, RAMIPRIL, |
||||
| 892 | 25131897 |
US |
67 | 2 |
Foot operation, Arthralgia, Foot fracture, Cyst, Foot deformity, Pain, Drug ineffective, Musculoskeletal stiffness, Foot deformity, Discomfort, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 893 | 25131912 |
US |
77 | 2 |
Drug ineffective, |
||||
LASMIDITAN, LASMIDITAN, |
||||
| 894 | 25131926 |
US |
83 | 2 |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 895 | 25131965 |
US |
52 | 1 |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 896 | 25131975 |
US |
2 | |
Diarrhoea, Intentional dose omission, Drug ineffective, Product use complaint, |
||||
TROFINETIDE, |
||||
| 897 | 25131980 |
US |
1 | |
Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 898 | 25131984 |
US |
1 | |
Condition aggravated, Adverse drug reaction, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 899 | 25131996 |
US |
||
Drug ineffective, |
||||
ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, |
||||
| 900 | 25132005 |
US |
||
Drug ineffective, Sinusitis, |
||||
RIBOCICLIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28